Related references
Note: Only part of the references are listed.LysGH15, a Novel Bacteriophage Lysin, Protects a Murine Bacteremia Model Efficiently against Lethal Methicillin-Resistant Staphylococcus aureus Infection
Jingmin Gu et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Bacteriophage Cocktail for the Prevention of Biofilm Formation by Pseudomonas aeruginosa on Catheters in an In Vitro Model System
Weiling Fu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Structural changes induced by a lytic bacteriophage make ciprofloxacin effective against older biofilm of Klebsiella pneumoniae
Vivek Verma et al.
BIOFOULING (2010)
Development of an Anti-Salmonella Phage Cocktail with Increased Host Range
Jiayi Zhang et al.
FOODBORNE PATHOGENS AND DISEASE (2010)
Bacteriophage Therapy of Salmonella enterica: A Fresh Appraisal of Bacteriophage Therapy
Rosanna Capparelli et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Bacteriophage Therapy: Exploiting Smaller Fleas
Stan Deresinski
CLINICAL INFECTIOUS DISEASES (2009)
Characterization of a T7-Like Lytic Bacteriophage of Klebsiella pneumoniae B5055: A Potential Therapeutic Agent
Vivek Verma et al.
CURRENT MICROBIOLOGY (2009)
Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment
Vivek Verma et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Quantitative Models of In Vitro Bacteriophage-Host Dynamics and Their Application to Phage Therapy
Benjamin J. Cairns et al.
PLOS PATHOGENS (2009)
Effect of Phage on the Infectivity of Vibrio cholerae and Emergence of Genetic Variants
M. Shamim Hasan Zahid et al.
INFECTION AND IMMUNITY (2008)
Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice
Sanjay Chhibber et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2008)
Taking aim on bacterial pathogens: from phage therapy to enzybiotics
Juan A. Hermoso et al.
CURRENT OPINION IN MICROBIOLOGY (2007)
Experimental phage therapy against Staphylococcus aureus in mice
Rosanna Capparelli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Dispersing biofilms with engineered enzymatic bacteriophage
Timothy K. Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice
Ryohei Watanabe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Selection of an Escherichia coli O157:H7 bacteriophage for persistence in the circulatory system of mice infected experimentally
R Capparelli et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Phage therapy: Facts and fiction
M Skurnik et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice
Y Tanji et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2005)
Isolation and characterization of novel giant Stenotrophomonas maltophilia phage φSMA5
HC Chang et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2005)
Toward rational control of Escherichia coli O157:H7 by a phage cocktail
Y Tanji et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2004)
Evidence for a phage proliferation threshold?
RJH Payne et al.
JOURNAL OF VIROLOGY (2002)
Characteristics of bacteremia between community-acquired and nosocomial Klebsiella pneumoniae infection -: Risk factor for mortality and the impact of capsular serotypes as a herald for community-acquired infection
RW Tsay et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Bacteriophage therapy
A Sulakvelidze et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin
JN Anderl et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
